Drug
Emicizumab
Emicizumab: highest development phase Phase 3, developed by Roche. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| Emicizumab NCT02622321 | Phase 3 | Hemophilia A |
| Emicizumab NCT02847637 | Phase 3 | Hemophilia A |
Latest
No recent events.
Follow Emicizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.